This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
chemicals: Archive
KRO vs. TROX: Which TiO2 Stock Deserves a Spot in Your Portfolio?
by Anindya Barman
KRO and TROX are seeing stronger TiO2 volumes and pricing, but weak demand, costs, leverage and market dynamics shape the outlook.
KROPositive Net Change TROXNegative Net Change
basic-materials chemicals
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
by Anindya Barman
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
APDPositive Net Change DDNegative Net Change IOSPPositive Net Change AVNTPositive Net Change
basic-materials chemicals
ALB Q2 Earnings Call Highlights Storage Demand, Q3 Pressure
by Zacks Equity Research
Albemarle sees tight lithium inventories and stronger storage demand, but warns Q3 Energy Storage sales, EBITDA and margins may decline sequentially.
ALBPositive Net Change
chemicals earnings
LYB Q2 Earnings Call Points to a Prolonged Supply Reset
by Zacks Equity Research
LyondellBasell says Middle East polyethylene outages may support margins beyond the near term as cost cuts and North American assets sharpen operating leverage.
LYBPositive Net Change
chemicals earnings
Is Kronos Worldwide Stock Still a Buy After a 36% YTD Rally?
by Anindya Barman
KRO gains on healthy long-term TiO2 demand, higher sales volumes, and cost and pricing actions that could strengthen margins and support future growth.
KROPositive Net Change TROXNegative Net Change CCNegative Net Change
basic-materials chemicals
4 Chemical Specialty Stocks to Gain From Demand Rebound
by Anindya Barman
Improving demand in major end markets augurs well for The Zacks Chemicals Specialty industry. ESI, FUL, KWR and MTX lean on cost cuts and efficiency moves to offset persistent inflation pressures.
ESINegative Net Change KWRPositive Net Change FULNegative Net Change MTXNegative Net Change
basic-materials chemicals
DOW vs. DD: Which Chemical Giant Deserves a Spot in Your Portfolio?
by Anindya Barman
DOW and DD are pursuing strategic growth strategies as demand and cost pressures persist.
DDNegative Net Change DOWPositive Net Change
basic-materials chemicals
FUL Stock Is Riding Medical, Aerospace and Pricing Trends
by Anindya Barman
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still clouds its path to stronger growth.
FULNegative Net Change MMMNegative Net Change AVYNegative Net Change
basic-materials chemicals
Is FUL Stock a Buy Now or a Value Trap for Cautious Investors?
by Anindya Barman
FUL trades near the low end of its five-year valuation range as improving earnings meet volume, inflation and leverage risks tied to its medical-market expansion.
FULNegative Net Change AVYNegative Net Change RPMPositive Net Change
basic-materials chemicals
H.B. Fuller Stock Outlook Hinges on Margins, Mix and M&A
by Anindya Barman
FUL's outlook rests on pricing, margins and portfolio reshaping as medical expansion and M&A aim to offset uneven demand across key end markets.
FULNegative Net Change AVYNegative Net Change RPMPositive Net Change
basic-materials chemicals